US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 7.090
  • -1.310-15.60%
Close Aug 9 16:00 ET
  • 7.090
  • 0.0000.00%
Post 20:01 ET
375.11MMarket Cap-631P/E (TTM)

Emergent BioSolutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Emergent BioSolutions Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 6, 2024

Revenue(YoY)

254.70M

-24.62%
EPS(YoY)

-5.38

-4.26%
Analyst Rating

Buy

Jul 31, 2024

Emergent BioSolutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 289.000M--
--2024/Q3-- / 266.000M--
Aug 6, 20242024/Q2254.700M / 190.000M--
May 1, 20242024/Q1300.400M / 220.250M--
Mar 6, 20242023/Q4276.600M / 274.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 289.000M--
--2024/Q3-- / 266.000M--
Aug 6, 20242024/Q2254.700M / 190.000M--
May 1, 20242024/Q1300.400M / 220.250M--
Mar 6, 20242023/Q4276.600M / 274.000M--

Unlock Free Earnings Estimates

Emergent BioSolutions Earnings Reports

  • Emergent BioSolutions | 10-Q: Q2 2024 Earnings Report

    Aug 7 14:33 ET

  • Emergent BioSolutions | 10-Q: Q1 2024 Earnings Report

    May 2 13:50 ET

  • Emergent BioSolutions | 10-K: FY2023 Annual Report

    Mar 8 16:28 ET

  • Emergent BioSolutions: Q3 2023 Earnings Report

    Dec 11, 2023 07:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg